🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ruthann Norman

ORCID: 0000-0003-0691-1350
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study”.

Impact of age‐related T‐cell dynamics on the identification of biomarkers predictive of immunotherapy discontinuation: A prospective cohort study

Aging and Cancer(2020)10.1002/aac2.12012
N/A
0DataRank · unranked
1 citations

Andrea M. Holderbaum, Namrata Arya, Suohui Zhang, Michael S. Bodnar, Ruthann Norman +5 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552
N/A
0DataRank · unranked
36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1
N/A
0DataRank · unranked
0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more